品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | E126576-10mg | 10mg | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
阿拉丁 | E126576-50mg | 50mg | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
阿拉丁 | E126576-100mg | 100mg | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
阿拉丁 | E126576-250mg | 250mg | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
阿拉丁 | E126576-1g | 1g | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
阿拉丁 | E421607-1ml | 1ml | 现货 | 143664-11-3 |
依克立达 Elacrida |
10mM in DMSO |
|
|
阿拉丁 | E126576-1mg | 1mg | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
阿拉丁 | E126576-25mg | 25mg | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
阿拉丁 | E126576-5mg | 5mg | 现货 | 143664-11-3 |
依克立达 Elacrida |
Moligand™, ≥98% |
|
|
梯希爱 | E1371-25MG | 25MG | 现货 | 143664-11-3 |
依克立达 Elacrida |
98.0% |
|
|
梯希爱 | E1371-100MG | 100MG | 现货 | 143664-11-3 |
依克立达 Elacrida |
98.0% |
|
|
阿法埃莎 | C46495-1GR | 1GR | 现货 | 143664-11-3 |
Elacridar Elacrida |
|
|
|
阿法埃莎 | C46495-250MG | 250MG | 现货 | 143664-11-3 |
Elacridar Elacrida |
|
|
|
毕得 | BD127191-250mg | 250mg | 现货 | 143664-11-3 |
N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-... N-(4-(2-(6,7-Dimethoxy-3,4-d... |
98% |
|
|
毕得 | BD127191-1g | 1g | 现货 | 143664-11-3 |
N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-... N-(4-(2-(6,7-Dimethoxy-3,4-d... |
98% |
|
|
毕得 | BD127191-5mg | 5mg | 现货 | 143664-11-3 |
N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-... N-(4-(2-(6,7-Dimethoxy-3,4-d... |
98% |
|
|
毕得 | BD127191-10mg | 10mg | 现货 | 143664-11-3 |
N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-... N-(4-(2-(6,7-Dimethoxy-3,4-d... |
98% |
|
|
毕得 | BD127191-25mg | 25mg | 现货 | 143664-11-3 |
N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-... N-(4-(2-(6,7-Dimethoxy-3,4-d... |
98% |
|
|
毕得 | BD127191-50mg | 50mg | 现货 | 143664-11-3 |
N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-... N-(4-(2-(6,7-Dimethoxy-3,4-d... |
98% |
|
|
毕得 | BD127191-100mg | 100mg | 现货 | 143664-11-3 |
N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-... N-(4-(2-(6,7-Dimethoxy-3,4-d... |
98% |
|
|